
WHAT CONFLICTS ANY MEAN TO YOU
The fact that an analyst or the analyst's firm may have a
conflict of interest does not mean that his or her
recommendation is flawed or unwise. You should assess whether
the recommendation is wise for you.
It's up to you to educate yourself to make sure that any
investments you choose match your goals and tolerance for risk.
Analysts generally do not function as your financial adviser
when they make recommendations. They're not providing
individually tailored investment advice and they're not taking
your personal circumstances into consideration.
UNCOVERING CONFLICTS
In addition to paying close attention to the disclosures
that firms and analysts make, here are some steps you can take
to assess whether and to what extent analyst conflicts may
exist:
Identify the underwriter
Before you buy, confirm whether the analyst's firm
underwrote a recommended company's stock by looking at the
prospectus, which is part of the registration statement for
the offering. Note that firms are required to disclose in
research reports whether they managed or co-managed a public
offering. You'll find a list of the lead or managing
underwriters on the front cover of both the preliminary and
final copies of the prospectus. By convention, the name of the
lead underwriter—the firm that stands to make the most money
on the deal—will appear first, and any co-managers will
generally be listed second in alphabetical order. Other firms
participating in the deal will be listed only in the
"Underwriting" or "Plan of Distribution"
sections of the final supplement to the prospectus. You can
search for registration statements using the SEC's EDGAR
database at www.sec.gov/edgar.shtml.
The final supplement to the prospectus will appear in EDGAR as
a "424" filing.
Research ownership interests
A company's registration statement and its annual
report on Form 10-K will tell you who the beneficial owners of
more than five percent of a class of equity securities are.
Research reports on a company must disclose whether the
securities firm issuing the report beneficially owns one
percent or more of any class of common equity securities of
the subject company. In addition to the disclosure
requirements in the new rules, you may
be able to ascertain ownership by checking the following SEC
forms:
Schedules 13D and 13G
Any person who acquires a beneficial ownership of
more than five percent must file a Schedule 13D. Schedule
13G is a much abbreviated version of Schedule 13D that is
only available for use by a limited category of
"persons," such as banks, broker-dealers, or
insurance companies.
Forms 3, 4, and 5
Officers, directors, and beneficial owners of more
than 10 percent must report their holdings—and any changes
in their holdings—to the SEC on Forms 3, 4, and 5.
Form 144
If an analyst or a firm holds "restricted"
securities from the company (meaning those acquired in an
unregistered, private sale from the issuer or its
affiliates) then investors can find out whether the analyst
or the firm recently sold the stock by researching their
Form 144 filings.
UNLOCK THE MYSTERY OF LOCK-UPS
If the analyst's firm acquired ownership interests through
venture investing, the shares generally will be subject to a
"lock-up" agreement during and after the issuer's
initial public offering. Lock-up agreements prohibit company
insiders, from selling their shares for a set period of time
without the underwriter's permission. While an underwriter can
choose to end the period early, lock-ups generally last for 180
days after the offering's registration statement.
After the lock-up period ends, the firm may be able to
sell the stock. If you're considering investing in a company
that has recently conducted an initial public offering, you'll
want to check whether a lock-up agreement is in effect. This is
important information because a company's stock price may be
affected by the prospect of lock-up shares being sold into the
market when the lock-up ends. It is also a data point you can
consider when assessing research reports issued just before a
lock-up period expires which are sometimes known as booster shot
reports.